MyFinsight
Home
Blog
About
Contact
Download
Download image
Total comprehensive
loss
-$17,496K
(4.28%↑ Y/Y)
Unrealized gain on
marketable securities
$84K
(-45.45%↓ Y/Y)
Net loss
-$17,580K
(4.62%↑ Y/Y)
Other income, net
$1,791K
(32.08%↑ Y/Y)
Loss from operations
-$19,371K
(2.11%↑ Y/Y)
Total operating
expenses
$19,371K
(-2.11%↓ Y/Y)
Research and development
$12,034K
(-9.79%↓ Y/Y)
General and
administrative
$7,337K
(13.79%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
RAPT Therapeutics, Inc. (RAPT)
RAPT Therapeutics, Inc. (RAPT)